MAM
SBBP

Meeder Asset Management’s Strongbridge Biopharma plc. SBBP Stock Holding History

Meeder Asset Management’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11,778
Closed -$26K – 2383
2020
Q3 		$26K Hold
11,778
– – ﹤0.01% 1102
2020
Q2 		$45K Buy
11,778
+73
+0.6% +$219 ﹤0.01% 949
2020
Q1 		$22K Buy
11,705
+11,648
+20,435% +$30.3K ﹤0.01% 1214
2019
Q4 		$0 Buy
+57
New +$109 ﹤0.01% 2493
2018
Q2 		– Sell
-101
Closed -$1K – 1730
2018
Q1 		$1K Buy
+101
New +$756 ﹤0.01% 1509
2017
Q4 		– Sell
-229
Closed -$2K – 1854
2017
Q3 		$2K Buy
229
+38
+20% +$262 ﹤0.01% 1505
2017
Q2 		$1K Buy
+191
New +$883 ﹤0.01% 1582

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Meeder Asset Management's SBBP Position: Q4 2020 in Review

Meeder Asset Management sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2020, closing a stake of 11,778 shares — an estimated $26K sold.

Meeder Asset Management first reported a position in SBBP in Q2 2017 and held it in 7 quarters. The position peaked at $45K in Q2 2020. 71 funds tracked by Wall St. Rank hold SBBP as of Q4 2020.

  • Meeder Asset Management reported no remaining Strongbridge Biopharma plc. position as of Q4 2020 after selling out during the quarter.
  • Meeder Asset Management sold 11,778 Strongbridge Biopharma plc. shares in Q4 2020, an estimated $26K.
  • Meeder Asset Management first reported a position in Strongbridge Biopharma plc. in Q2 2017 and held it in 7 quarters.
  • Meeder Asset Management's Strongbridge Biopharma plc. position peaked at $45K in Q2 2020.
  • 71 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2020.

Based on Meeder Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.